(NASDAQ: QTTB) Q32 Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.07%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31%.
Q32 Bio's earnings in 2026 is $33,786,000.On average, 7 Wall Street analysts forecast QTTB's earnings for 2026 to be -$46,383,805, with the lowest QTTB earnings forecast at -$47,729,385, and the highest QTTB earnings forecast at -$43,260,988. On average, 8 Wall Street analysts forecast QTTB's earnings for 2027 to be -$55,168,774, with the lowest QTTB earnings forecast at -$67,100,376, and the highest QTTB earnings forecast at -$37,854,853.
In 2028, QTTB is forecast to generate -$58,401,738 in earnings, with the lowest earnings forecast at -$75,852,599 and the highest earnings forecast at -$31,570,519.